Aclaris Therapeutics

IPO

Home | Aclaris Therapeutics Inc.

Aclaris Therapeutics was founded in 2012, is headquartered in St. Louis, United States, lists 11–50 employees, and has $122.0M in recorded funding across 3 rounds.

Employees
11–50
Founded
2012
Business Model
B2B
Total Funding
$122.0M
Last Round
$80.0M Private EquityJan 2020
Rounds
3
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 3 investors for this company. The full record is or through the API.

About

Aclaris Therapeutics focuses on drug discovery and development and kinase inhibition to create novel small and large molecule drugs for people impacted by underserved immuno-inflammatory conditions. Scientists use the proprietary KINect technology platform to design kinase inhibitors that target enzymes involved in chronic inflammation, autoimmune disease, and the regulation of cancer growth. The company also develops biologic candidates such as monoclonal and bispecific antibodies that target validated immune-inflammatory pathways, and operates Confluence Discovery Technologies as a drug-discovery contract research organization for pharma and biotech partners.

Summary

Aclaris Therapeutics is a Biotech company based in St. Louis, United States, founded in 2012. It lists 11–50 employees. It has raised $122.0M in total across 3 rounds, most recently a $80.0M Private Equity round in Jan 2020. Investors include Vivo Capital, Fidelity Biosciences and Sofinnova Partners.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Private EquityPrivate Equity2020 (est.)
$80.0M

Sign up to see all 4 events

Funding: Series A through Private Equity. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Aclaris Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/aclaris-therapeutics"><img src="https://indexed.vc/api/badge/company/aclaris-therapeutics" alt="Aclaris Therapeutics on Indexed.vc" width="260" height="76" /></a>